Dr Rooshi Nathwani

MBBS, MSc, MRCP (Gastro), PhD

Consultant in Hepatology, Gastroenterology and General Internal Medicine

Dr Rooshi Nathwani is a Consultant Hepatologist at the Royal Free Hospital, London, with extensive expertise in hepatology, gastroenterology, and general internal medicine. He completed his specialty training in the North-West London Deanery and undertook advanced hepatology training at the Royal Free and Imperial College London Hospitals. Currently, he serves as the Clinical Lead for Hepatology Early Detection Pathways at the Royal Free Hospital.

Dr Nathwani has a strong clinical background focused on complex liver diseases, including alcohol-related liver disease, decompensated cirrhosis, portal hypertension, vascular liver diseases, metabolic dysfunction-associated steatotic liver disease (MASLD), and early detection of liver disease. His clinical skills include proficiency in Fibroscan and both diagnostic and therapeutic upper GI endoscopy.

He earned his PhD from Imperial College London and has contributed to multiple peer-reviewed publications on liver disease. Dr Nathwani remains actively involved in clinical research and is dedicated to medical education, organizing teaching programs and delivering lectures at prestigious hepatology courses. Fluent in Gujarati, Dr Nathwani prides himself on providing exceptional, patient-centered care.

Hospital Locations

Royal Free Hospital, Hadley Wood Hospital

Year qualified

2009

Country of qualification

Languages spoken

Gujrati

Specialities

Hepatology
Gastroenterology
General Internal Medicine

Memberships

British Association for the Study of the Liver (BASL)
British Society of Gastroenterology (BSG)
European Association for the Study of the Liver (EASL)

Registration and licensing

GMC:7041063

Procedures offered

Fibroscan
Diagnostic Gastroscopy
Therapeutic Gastroscopy including variceal band ligation, glue and injection therapy and treatment for acute bleeding.

Clinical interests

Early Detection of liver disease
Abnormal Liver Function Tests
Fatty Liver Disease
Alcohol related liver disease
Liver Cirrhosis
Cirrhosis and its complications
Portal Hypertension

Research interests

Portal Hypertension
Infections in Liver Cirrhosis
Cirrhosis and its complications

Published papers

Nathwani R, Selvapatt N, Dhar A. Decompensation and Acute on Chronic Liver Failure. Liver Disease in Clinical Practice. 2022; 57-79.
Nathwani R, Mullish BH, Koeckerling D et al., Review of Rifaximin: A Summary of the Current Evidence and Benefits Beyond Licensed Use. EMJ Hepatology. 2021;6(3):94-99.
Nathwani R, Koerckerling D, Mullish BH et al., Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infections. Frontline Gastroenterology. 2021;13(1):101818
Nathwani R, Mukherjee S, Forlano et al., Letter: Liver Disease and COVID-19 – not the perfect storm. AP&T. 2020;52(3):572-574
Nathwani R, Mullish BH, Koeckerling D et al., A Review of Liver Fibrosis and Emerging Therapies. EMJ Hepatology. 2019;4(4):105-116.
Nathwani R, Mullish BH, Koeckerling D et al., Recurrent bacteraemia following variceal haemorrhage. GUT. 2019;69(4).
Koeckerling D, Nathwani R, Mullish BH et al., Current and future pharmacological therapies for managing cirrhosis and its complications. WJG. 2019;25(8):888-908.